Literature DB >> 30740617

Factors influencing magnesium infusions in hematopoietic cell transplants.

Michael S Gin1, Todd W Canada2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30740617     DOI： 10.1007/s00520-019-04686-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  8 in total

1.  Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy.

Authors:  C Raghu; P Peddeswara Rao; D Seshagiri Rao
Journal:  Int J Cardiol       Date:  1999-12-01       Impact factor: 4.164

2.  Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients.

Authors:  Pam M Ku; Jennifer L Waller; Claude Sportès; Amber B Clemmons
Journal:  Support Care Cancer       Date:  2018-03-05       Impact factor: 3.603

3.  Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.

Authors:  Tania Weber Furlanetto; Gustavo Adolpho Moreira Faulhaber
Journal:  Arch Intern Med       Date:  2011-05-09

4.  Intravenous magnesium in acute myocardial infarction.

Authors:  H S Rasmussen; P McNair; P Norregard; V Backer; O Lindeneg; S Balslev
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

5.  Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

Authors:  K L Woods; S Fletcher; C Roffe; Y Haider
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

6.  Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplant.

Authors:  Matthew Snyder; Alexandra Shillingburg; Michael Newton; Mehdi Hamadani; Abraham S Kanate; Michael Craig; Aaron Cumpston
Journal:  Support Care Cancer       Date:  2016-05-02       Impact factor: 3.603

7.  Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy.

Authors:  M Shechter; H Hod; P Chouraqui; E Kaplinsky; B Rabinowitz
Journal:  Am J Cardiol       Date:  1995-02-15       Impact factor: 2.778

8.  Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial.

Authors:  R J Hamill-Ruth; R McGory
Journal:  Crit Care Med       Date:  1996-01       Impact factor: 7.598
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.